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Abstract Serotonin [5-hydroxytryptamine (5-HT)], an in-
flammatory mediator, contributes to inflammatory pain. The
presence of multiple 5-HTsubtype receptors on peripheral and
central nociceptors complicates the role of 5-HT in pain.
Previously, we found that 5-HT2B/2C antagonist could block
5-HT-induced mechanical hyperalgesia. However, the types
of neurons or circuits underlying this effect remained un-
solved. Here, we demonstrate that the Gq/11-phospholipase
Cβ-protein kinase Cε (PKCε) pathway mediated by 5-HT2B
is involved in 5-HT-induced mechanical hyperalgesia in mice.
Administration of a transient receptor potential vanilloid 1
(TRPV1) antagonist inhibited the 5-HT-induced mechanical
hyperalgesia. 5-HT injection enhanced 5-HT- and capsaicin-
evoked calcium signals specifically in isolectin B4 (IB4)-
negative neurons; signals were inhibited by a 5-HT2B/2C an-
tagonist and PKCε blocker. Thus, 5-HT2B mediates 5-HT-
induced mechanical hyperalgesia by regulating TRPV1
function.
Keywords Serotonin . 5-HT2B .Mechanical hyperalgesia .
Protein kinase Cε . Transient receptor potential vanilloid 1
Introduction
Serotonin [5-hydroxytryptamine (5-HT)], released from plate-
lets, mast cells, and endothelial cells into the inflamed site, is
an important inflammatory mediator causing pain and
hyperalgesia (Dray 1995; Sommer 2004). More than one sub-
type of serotonin receptor is present in peripheral nociceptive
afferents (Hoyer et al. 2002). so each receptor may have dis-
tinct functions in 5-HT-induced pain. Use of specific receptor
agonists, antagonists, or gene-targeting techniques have clari-
fied the roles of 5-HT-receptor subtypes in pain. 5-HT-induced
mechanical hyperalgesia is inhibited by 5-HT2B/2C antagonist
but not 5-HT1A, 5-HT2A, or 5-HT3 antagonist (Lin et al.
2011). A formalin model further revealed that 5-HT4, 5-HT6,
and 5-HT7 are required for maintaining secondary mechanical
allodynia and hyperalgesia (Godinez-chaparro et al. 2012).
These findings suggest that 5-HT2B/2C could be involved in
inducing mechanical hyperalgesia, whereas 5-HT4/6/7 are re-
sponsible for maintaining the hyperalgesia. However, the
mechanisms of inducing and maintaining mechanical
hyperalgesia remain unsolved.
Several lines of evidence have suggested that Gq/11, Gi,
protein kinase Cε (PKCε), or phospholipase Cβ (PLCβ) is
involved in mechanical hyperalgesia (Khasar et al. 1999;
Joseph et al. 2007; Dina et al. 2009; Joseph and Levine
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hyperalgesia may be mediated by a Gq/11- or Gi-PLCβ-PKCε
pathway. The in vitro studies found that 5-HT2 receptors acti-
vate Gq/11 protein, thus leading to PKC activation (Loric et al.
1995; Lin et al. 2011). so 5-HT2B/2C may mediate 5-HT-
induced mechanical hyperalgesia through a Gq/11-PKC
pathway.
Studies in mice lacking transient receptor potential
vanilloid 1 (TRPV1) gene revealed that TRPV1 is involved
in thermal nociception and hyperalgesia (Caterina et al.
2000; Davis et al. 2000). but several lines of evidence
suggest that TRPV1 is involved in mechanical
hyperalgesia. TRPV1 antagonists inhibit CFA-, capsaicin,
or acid-induced mechanical hyperalgesia (Gavva et al.
2005; Honore et al. 2005; Cui et al. 2006; Chen et al.
2014). Spinal activation of TRPV1 leads to mechanical
allodynia, and TRPV1 antagonist can reverse this effect
(Kim et al. 2012). Endogenous activation of spinal
TRPV1 could be due to Gq/11-coupled receptors or arachi-
donic acid metabolites (Gibson et al. 2008; Kim et al.
2009; Kim et al. 2012). 5-HT potentiates TRPV1 function
through protein kinase A (PKA) or PKC (Sugiuar et al.
2004; Ohta et al. 2006). Whether TRPV1 is involved in
5-HT-induced mechanical hyperalgesia is unknown.
In this study, we demonstrated that 5-HT-induced mechan-
ical hyperalgesia is regulated by a 5-HT2B-Gq/11-PLCβ-PKCε
pathway. Administration of 5-HT strongly enhanced 5-HT-
and capsaicin-induced calcium signals in IB4-negative neu-
rons, and enhanced signals were regulated by the 5-HT2B-
Gq/11-PKCε pathway. Interestingly, 5-HT-induced mechanical
hyperalgesia was also inhibited by TRPV1 antagonist or in
mice lacking TRPV1 gene. 5-HT-induced mechanical
hyperalgesia may be mediated by a 5-HT2B-Gq/11-PLCβ-
PKCε pathway via regulating TRPV1 function.
Experimental Procedures
Animals
Male CD1 mice (8–12 weeks old) were bred and cared for in
accordance with the Guide for the Use of Laboratory Animals
(National Academy Press, Washington, DC). Animal experi-
mental procedures were approved by the local animal use com-
mittee (IACUC, National Central University, Taiwan). TRPV1−/
− mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA) and backcrossed to CD-1 mice for at least
ten generations to generate outbred TRPV1+/− mice. The
TRPV1+/+, TRPV1+/−, and TRPV1−/− mice were offspring of
a TRPV1+/− intercross. The genotyping primer sequences were
5 ′ - C A C G A G A C T A G T G A G A C G T G / 5 ′ -
TCCTCATGCACTTCAGGAAA for TRPV1−/− mice and 5′-
C C T G C T C A A C A T G C T C A T T G / 5 ′ -
TCCTCATGCACTTCAGGAAA for TRPV1+/+ mice.
Agents
5-HT, pertussis toxin (PTX) (Lin et al. 2011; Dina et al. 2009).
capsaicin, capsazepine (N-[2-(4-chlorophenyl)ethyl]-1,3,4,5-
tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbo thioamide)
(Zhang et al. 2007). and U73122 (1-[6-[[(17b)-3-methoxyestra-
1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) (Hou
et al. 2004; Joseph et al. 2007;Lin et al. 2011) were from
Sigma (St. Louis, MO). Granisetron hydrochloride (1-methyl-
N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-
indazole-3-carboxamide hydrochloride) (Kayser et al. 2007; Lin
et al. 2011). SB206553 hydrochloride (3,5-dihydro-5-methyl-N-
3-pyridinylbenzo[1,2-b:4,5-b′]dipyrrole-1(2H)-carboxamide hy-
drochloride)[7], H89 dihydrochloride (N-[2-[[3-(4-
b r om o p h e n y l ) - 2 - p r o p e n y l ] am i n o ] e t h y l ] - 5 -
isoquinolinesulfonamide dihydrochloride) (Zhang et al. 2007;
Chen et al. 2008). SQ22536 (9-(tetrahydro-2-furanyl)-9H-
purin-6-amine) (Villarreal et al. 2009; Sachs et al. 2009) and
RS127445 hydrochloride (4-(4-fluoro-1-naphthalenyl)-6-(1-me
thylethyl)-2-pyrimidinamine hydrochloride)(Urtikova et al.
2012) were from Tocris Bioscience (Bristol, UK). PKCεV1–2
peptide conjugated with protein transduction domain of TAT
protein (CYGRKKRRQRRR-CEAVSLKPT, TAT-PKCεV1–2)
(Schwarze et al. 1999; Parada et al. 2005; Sachs et al. 2009)
was kindly provided by KAI Pharmaceuticals, Inc. (CA, USA).
For animal experiments, all drugs or peptides were diluted in
saline before injection. For cell experiments, all drugs or peptides
were diluted in (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) (HEPES)/2-ethanesulfonic acid (MES) buffer (125 mM
NaCl, 1 mM KCl, 5 mM CaCl2, 1 mMMgCl2, 8 mM glucose,
10 mM HEPES, and 15 mMMES, pH 7.6).
Behavioral Tests
Pain-behavioral tests were described previously (Lin et al.
2011). Briefly, male CD-1, TRPV1+/+, TRPV1+/−, and
TRPV1−/−mice (8–12 weeks old) were intraplantarly injected
with 25 μl 5-HT, receptor antagonists or inhibitors, then
underwent animal behavioral tests for withdrawal thresholds
to mechanical stimuli applied to the hindpaw (von Frey fila-
ments, Touch-Test; North Coast Medical, Morgan Hill, CA).
Mice (n = 6 per group) were pre-trained for 2 h each day for
2 days before the test. A series of von Frey fibers (0.6, 1.4, 2.0,
4 g) were applied to the plantar surface of each hindpaw five
times at 5-s intervals after injections. The paw withdrawal
threshold (PWT) was determined when paw withdrawal was
observed in more than three of five applications.
Primary Cell Culture
Primary dorsal root ganglia (DRG) were cultured as described
(Lin et al. 2011). Briefly, mice were pre-injected with or with-
out 5-HT2B/2C antagonist SB206553, then with 5-HT. After
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30 min, mouse lumbar 4–6 DRGs were collected in pre-
warmed serum-free Dulbecco’s modified Eagle’s medium
(DMEM). After collagenase IA and trypsin treatments, cells
were washed in medium and re-suspended in 2 ml serum-free
DMEM, then dissociated into single cells by mechanical titra-
tion. Cell suspension was slowly dropped into 10 ml serum-
free DMEM. After 3∼5 min, the cell suspension on the top
(∼10 ml) was collected and centrifuged at 1224×g for 5 min.
The cell pellet was suspended and mixed in 400 μl DMEM
containing 10 % fetal bovine serum (FBS) and seeded on
100 μg/ml poly-L-lysine-coated 24-mm coverslips. After in-
cubation at 37 °C for 2 h, cells were supplemented with 1.5 ml
DMEM containing 10 % FBS and maintained at 37 °C for 12
to 14 h before intracellular Ca2+ imaging.
Intracellular Calcium Imaging
Intracellular calcium imaging was performed as described
(Chen et al. 2009; Lin et al. 2011). Primary cultured neurons
grown on coverslips were washed once with serum-free me-
dium and pre-incubated at 37 °C with 1.25 μM Fura-2
acetoxymethyl ester (Fura-2-AM; Molecular Probes) for
40 min in HEPES/MES buffer. Coverslips were assembled
into culture wells and supplemented with 500 μl HEPES/
MES buffer. Cells were stimulated with 500 μl HEPES/
MES buffer containing 2-fold concentrations of 5-HT, antag-
onists, or inhibitors, then underwent intracellular calcium re-
cording with use of a Zeiss inverted microscope equipped
with a xenon lamp. Cell images were taken with use of a
Zeiss Plan-Apo 63X oil-immersion objective lens. Fura-2-
AM fluorescence was measured by 10 Hz alternating-
wavelength time scanning, with 340 and 380 nm excitation
and 510 nm emission. The fluorescence ratio at two excitation
wavelengths (340/380 nm, Ca2+-bound Fura-2-AM/free Fura-
2-AM) was recorded and analyzed. After recording, cells were
stained with IB4-FITC conjugates (5 μg/ml) for 15 min and
washed with phosphate-buffered saline. IB4-FITC-labeled
cells were identified by use of a FITC filter at 480 nm excita-
tion and 535 nm emission.
In Situ Hybridization and Immunohistochemistry
In situ hybridization and immunohistochemistry were per-
formed as previously described (Lin et al. 2011). Briefly, lum-
bar 4 DRG tissues were frozen and sectioned in 12-μm-thick
slices. Sections were hybridized with 5-HT2B-digoxigenin-
UTP (dig, Roche)-labeled complementary RNA (cRNA)
probes, followed by detection with an alkaline-phosphatase-
conjugated anti-dig antibody (Roche). Some sections in-
volved direct staining with IB4-FITC conjugates
(12.5 μg/ml, Sigma). The specimens were examined by use
of a ×20 objective with a fluorescence microscope (Zeiss,
Axiovert 200, Germany). The digitized images were captured
and the neuron size was measured by MetaMorph software.
Statistical Analysis
All data are presented as mean ± SEM. One- or two-way anal-
ysis of variance (ANOVA) with post hoc Bonferroni test was
used to compare results frommultiple groups. The statistically
significant levels were set at *p < 0.05, **p < 0.01, and ***p
< 0.001.
Results
5-HT-Induced Mechanical Hyperalgesia Is Regulated
by the 5-HT2B-Gq-PLCβ-PKCε Pathway
We previously found that 5-HT-induced mechanical
hyperalgesia was inhibited by the 5-HT2B/2C antagonist
SB206553 (Lin et al. 2011). To determine whether 5-HT2B
or 5-HT2C mediated the 5-HT-induced mechanical
hyperalgesia, we administered the selective antagonist of 5-
HT2B (RS127445). The effect doses for RS127445 were 0.25
and 0.5 nmol (Fig. 1a). In agreement with the previous study
(Lin et al. 2011). 5-HT injection into the mouse hindpaw in-
duced mechanical hyperalgesia within 30 min, which disap-
peared at 4 h (Fig. 1c). Administration of RS127445 at the
dose of 0.5 nmol completely inhibited mechanical
hyperalgesia induced by 5-HT (Fig. 1d). It is confirmed that
5-HT2B mediated 5-HT-induced mechanical hyperalgesia. 5-
HT binding to 5-HT2B receptors activated Gq protein, thus
activating PLCβ, then PKC and increased intracellular calci-
um concentration (Loric et al. 1995; Lin et al. 2011). To fur-
ther confirm that the Gq-PLCβ-PKC pathway is involved in 5-
HT2B-mediated mechanical hyperalgesia, we tested the doses
of PKCε or PKA inhibitors. PKCε or PKA inhibitors were
injected before 5-HT injection, and mechanical hyperalgesia
was tested at 30 min after 5-HT injection. PKA inhibitor
(H89) did not block 5-HT-induced hyperalgesia even in
2.5 nmol dose (Fig. 1b), but 1.25 nmol of PKA inhibitor
was able to reduce CFA-inducedmechanical hyperalgesia (da-
ta not shown). The dose of 1.25 nmol for PKAwas used in the
following experiments. PKCε inhibitor (PKCεI, peptide V1–2)
reduced 5-HT-induced hyperalgesia at the dose of 0.75 nmol
and completely block hyperalgesia at 1.25 nmol. The dose of
1.25 nmol for PKCεI was used in the following experiments
(Fig. 1b).We then examined the effects of PKAI and PKCεI at
different times after 5-HT injection. With injection of
1.25 nmol PKCεI before 5-HT injection, the hyperalgesia to
mechanical stimuli was completely inhibited within 30 min
(3.67 ± 0.33 g on the PKCεI-injected ipsilateral paw and 1.42
± 0.15 g on the 5-HT-injected ipsilateral paw, Fig. 1e) and the
inhibition lasted at least 4 h. Similar experiments blocking
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PKA with H89 could not inhibit 5-HT-induced mechanical
hyperalgesia (1.33 ± 0.07 g on the PKAI-injected ipsilateral
paw Fig. 1e). We then examined the involvement of G-
protein signaling in 5-HT-induced mechanical hyperalgesia.
The effective doses for SQ22536, U73122, and PTXwere first
tested in CFA model (data not shown). The dose of 5.1 μg of
adenylyl cyclase (AC) inhibitor SQ22536, 5.8 μg of PLCβ
inhibitor (U73122), or 100 ng of Gi/o protein inhibitor (PTX)
was injected into mouse paw. Only PLCβ blocker but not AC
or Gi/o protein inhibitor could inhibit 5-HT-induced
mechanical hyperalgesia (Fig. 1f). Therefore, 5-HT-induced
mechanical hyperalgesia was mediated by the 5-HT2B-Gq-
PLCβ-PKCε pathway.
Enhanced 5-HT-Induced Calcium Signals Are Regulated
by 5-HT2B-PLCβ-PKCε Signaling
In a previous study (Lin et al. 2011). we found that 5-HT-
induced calcium signals in cultured DRG neurons had two
patterns: (1) transient increase and (2) transient increase and
Fig. 1 5-HT2B mediates 5-HT-induced mechanical hyperalgesia through
phospholipase Cβ (PLCβ) and protein kinase Cε (PKCε). a Wild-type
CD1 mice (8–12 weeks old) were intraplantarly injected with different
doses of 5-HT2B antagonist (RS127445 (RS)) before 5-HT injection.
Mechanical tests were performed and the threshold of paw withdrawal
(PWT) was measured at 30 min. Data are mean ± SEM PWT of total
tested mice (n ≥ 6 per group). Comparisons between inhibitor-injected
groups and inhibitor-uninjected groups were done by one-way ANOVA
with a post hoc Bonferroni test. ***p < 0.001. bMice were intraplantarly
injected with 25 μl of different doses of PKA inhibitor (PKAI; H89) or
PKCε inhibitor (PKCεI; TAT-PKCεV1–2) before 5-HT injection. The
PWT was measured at 30 min (for PKAI) or 60 min (for PKCεI) after
5-HT injection. Inhibitor-injected groups were compared with inhibitor-
uninjected groups by one-way ANOVAwith a post hoc Bonferroni test.
***p < 0.001. c Mice were injected with 5-HT, followed by mechanical
tests at different times. Ipsilateral PWTs were compared with contralateral
PWTs by two-way ANOVA with a post hoc Bonferroni test.
***p < 0.001. d Mice were pre-injected with RS (20 μM) before 5-HT
injection, followed by mechanical tests at different times. Comparisons
between the ipsilateral PWTs of 5-HT-injected and RS/5-HT-injected
animals were done by two-way ANOVA with a post hoc Bonferroni
test. ##p < 0.01; ###p < 0.001. e Mice were pre-injected with PKCεI
(50 μM) or PKAI (50 μM) before 5-HT injection. PWT for ipsilateral
paw was measured at different times. The ipsilateral PWTs of 5-HT/
inhibitor- were compared with the ipsilateral PWTs of 5-HT-injected
animals by two-way ANOVA with a post hoc Bonferroni test.
##p < 0.01; ***p < 0.001; ###p < 0.001. f Mice were pre-injected with
AC inhibitor (SQ22536 (SQ), 1 mM), Gi inhibitor (pertussis toxin
(PTX), 4 ng/μl) or PLCβ inhibitor (U73122, 500 μM) before 5-HT
injection. PWT for ipsilateral paw was measured at different times.
Comparisons between ipsilateral PWTs of 5-HT/inhibitor- and
ipsilateral PWTs of 5-HT-injected animals (number sign), were done by
two-way ANOVAwith a post hoc Bonferroni test. ###p < 0.001
116 J Mol Neurosci (2016) 59:113–125
sustained return. Only pattern 1 was significantly enhanced
after 5-HT injection. However, the subsets of DRG neurons
with the enhanced signals remained unknown. We cultured
DRG neurons from mice after 5-HT injection and examined
5-HT-induced calcium signals. Consistent with previous find-
ings, 5-HT-induced calcium signals had 2 patterns. Pattern 2
occurred only in IB4-positive neurons, but pattern 1 appeared
in both IB4-positive and IB4-negative neurons (Fig. 2a–f). The
peak of pattern 2 signals did not change after 5-HT injection
(Fig. 2h). After 5-HT injection, pattern 1 signals were 3-fold
enhanced in IB4-negative neurons (0.035 ± 0.021 contralateral
side vs. 0.106 ± 0.022 ipsilateral side), but remained un-
changed in IB4-positive neurons (Fig. 2g). Although pattern
1 signals in IB4-positive neurons were not enhanced, the num-
ber of 5-HT responsive neurons was increased (2.5 % contra-
lateral side vs. 5.2 % ipsilateral side). The number of 5-HT-
responsive IB4-negative neurons was also increased (1.7 vs.
5.9 %). 5-HT-responsive neurons were 10 to 25 μm in diam-
eter, with most being 10 to 15μm in diameter and increased in
proportion after 5-HT injection (total responsive neurons are
5.1 % on contralateral and 13.3 % on ipsilateral sides, Fig. 3a,
b). In situ hybridization revealed that neurons expressing 5-
HT2B were 5 to 35 μm in diameter, with most 10 to 25 μm
(Fig. 3c). The size of 5-HT2B-expressing neurons was corre-
lated with the size of 5-HT-responsive neurons, which sug-
gested that 5-HT2B mediated 5-HT-induced signals in small-
diameter neurons (10 to 25 μm). Immunostaining of DRG
sections revealed that among the 10- to 25-μm diameter neu-
rons, IB4-positive immunoreaction was mainly located in neu-
rons 15 to 25 μm in diameter (Fig. 3d). This finding was
consistent with IB4 staining of cultured DRG neurons. 5-HT-
responsive neurons <15 μm were mainly IB4 negative. 5-HT-
Fig. 2 IB4-negative neurons
show enhanced calcium signals
after 5-HT injection. Lumbar 4–6
dorsal root ganglia (DRG)
ipsilateral or contralateral to the 5-
HT-injected mouse paw were
cultured for 12 h, then stimulated
with 5-HT (1 μM), and
intracellular calcium change was
recorded for 600 s. After
recording, neurons were pulse
labeled with IB4-FITC (5 μg/ml)
for 10min. Time-dependent mean
calcium increase in IB4-negative
(IB4−) neurons (a, b) and IB4-
positive (IB4+) neurons (c–f). The
peak values were represented in
the histograms (g, h).
Comparisons between ipsilateral
and contralateral DRG neurons of
5-HT-injected animals were done
by two-way ANOVAwith a post
hoc Bonferroni test. #p < 0.05
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enhanced calcium signals were also in IB4-negative popula-
tion (Fig. 2h).
Consistent with previous findings (Lin et al. 2011). injec-
tion of a 5-HT2B/2C antagonist inhibited pattern 1 signals and
the transient signals in pattern 2; pattern 1 signals were
completely inhibited in both IB4-positive and IB4-negative
neurons (Fig. 4a). The number of 5-HT-responsive neurons
was also decreased (1.3 % with SB206553 and 5-HT injection
vs. 13 % with 5-HT injection).
To examine whether 5-HT-induced pattern 1 calcium signals
depend on PLCβ, we treated neurons with the PLCβ inhibitor,
U73122. Signal pattern 1 was inhibited by the addition of
U73122 in both IB4-positive and IB4-negative neurons
(Fig. 4b), suggesting that pattern 1 calcium signals are regulated
by PLCβ.We then used the PKCε blocker PKCεI to examine 5-
HT-induced calcium signals. PKCεI completely inhibited 5-HT-
induced calcium signals in IB4-negative neurons, but only par-
tially blocked calcium signals in IB4-positive neurons (Fig. 4c).
Enhanced 5-HT-Induced Calcium Signals Are Regulated
by a 5-HT2B-PKCε-Dependent Pathway
In IB4-positive neurons, 5-HT-induced calcium signaling
remained unchanged in some 5-HT-responsive neurons with
EGTA treatment to remove extracellular calcium (Fig. 5a, b),
but was completely inhibited in some other neurons (Fig. 5c,
d). In IB4-negative neurons, 5-HT-induced signals were
sensitive to removal of extracellular calcium (Fig. 5e, f).
Therefore, calcium signals from some 5-HT-responsive IB4-
positive neurons are from the endoplasmic reticulum (ER) and
are directly induced by 5-HT2 activation. However, calcium
signals from other 5-HT-responsive IB4-positive neurons and
all 5-HT-responsive IB4-negative neurons are from extracellu-
lar pools through unknown channels. It may explain that 5-
HT-induced calcium signals were only partially inhibited by
PKCεI in IB4-positive neurons because 5-HT2B-mediated cal-
cium release from ER is insensitive to EGTA. In IB4-negative
neurons, 5-HT-induced calcium signals were from extracellu-
lar pools and regulated by PKCε.
One possibility for calcium influx is due to 5-HT3. In IB4-
negative neurons, the addition of a 5-HT3 antagonist
granisetron could not inhibit 5-HT-induced calcium signals
(Fig. 5g). In IB4-positive neurons, 5-HT-induced calcium sig-
nals were inhibited by the 5-HT3 antagonist in some neurons
but remained unchanged in some neurons (Fig. 5g). The par-
tial inhibition of granisetron in IB4-positive neurons suggested
that calcium signals were partially sensitive to EGTA.
Thus, in IB4-positive neurons, some 5-HT-induced calcium
signals are released from an internal Ca2+ store that is directly
induced by 5-HT2B/2C activation and some from extracellular
influx through 5-HT3 or other calcium channels regulated by a
5-HT2B/2C-PKCε pathway. In IB4-negative neurons, all 5-HT-
induced calcium signals are from Ca2+ influx and are regulat-
ed by a 5-HT2B/2C-PKCε pathway.
Fig. 3 5-HT-responsive neurons are small-diameter neurons. a, b
Lumbar 4–6 DRG ipsilateral or contralateral to the 5-HT-injected
mouse paw were cultured for 12 h, then stimulated with 5-HT (1 μM),
and intracellular calcium change was recorded for 600 s. The diameter of
neurons was measured by MetaMorph software. Histograms show
proportion of 5-HT-responsive neurons to total recorded neurons. c, d
Lumbar DRG tissues were sectioned and hybridized with DIG-labeled
5-HT2B antisense cRNA probes (c) or directly stained with IB4-FITC
conjugates (d). The diameter of neurons was measured by MetaMorph
software. Histograms show proportion of c 5-HT2B-positive neurons to
total neurons and d IB4-positive or IB4-negative subpopulations to
respective total neurons
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TRPV1 Is Involved in 5-HT-Induced Mechanical
Hyperalgesia
Previous studies suggested that TRPV1 function is enhanced
by 5-HT (Sugiuar et al. 2004; Ohta et al. 2006) and TRPV1 is
involved in capsaicin-, acid-, or CFA-induced mechanical
hyperalgesia (Gavva et al. 2005; Honore et al. 2005; Cui et
al. 2006; Chen et al. 2014). Thus, we examined whether
TRPV1 is involved in 5-HT-inducedmechanical hyperalgesia.
The administration of the TRPV1 antagonist capsazepine
(0.25 nmol) before 5-HT injection completely inhibited
hyperalgesia to mechanical stimuli within 30 min and lasted
at least 4 h (Fig. 6a).We further validated the role of TRPV1 in
5-HT-induced mechanical hyperalgesia using TRPV1-
deficient mice. 5-HT injection induced mechanical
hyperalgesia in TRPV1+/− and TRPV1+/+ but not TRPV1−/−
mice (Fig. 6b). The results suggested that TRPV1 participates
5-HT-induced mechanical hyperalgesia.
We next examined whether TRPV1 function is regulated
by 5-HT2B-mediated signaling. Capsaicin-induced calcium
signals were greater in IB4-positive than -negative neurons
(0.155 ± 0.042 vs. 0.051 ± 0.09 contralateral side; Fig. 7a),
which agrees with previous findings (Petruska et al. 2000,
2002; Liu et al. 2004). After 5-HT injection, capsaicin-
induced calcium signals were increased in IB4-negative neu-
rons (0.245 ± 0.044 ipsilateral side vs. 0.051 ± 0.09 contralat-
eral side) but not IB4-positive neurons (Fig. 7a). Injection of 5-
HT2B/2C antagonist inhibited the 5-HT-enhanced capsaicin-
evoked signals in IB4-negative but not IB4-positive neurons
(Fig. 7b), which suggests that 5-HT-enhanced TRPV1 func-
tion in IB4 negative is regulated by 5-HT2B/2C. We further
examined whether PKCε regulates enhanced TRPV1 func-
tion. Capsaicin-evoked signals were also inhibited by PKCεI
in IB4-negative neurons (Fig. 7c). Accordingly, these results
suggests that 5-HT enhances TRPV1 function through the 5-
HT2B-PKCε pathway.
Discussion
Our previous findings suggested that 5-HT2B/2C antagonist
inhibited 5-HT-induced mechanical hyperalgesia. In this
study, we demonstrated that 5-HT2B-PLCβ-PKCε pathway
and TRPV1 function are involved in 5-HT-induced mechani-
cal hyperalgesia because administration of antagonists for 5-
HT2B, PLCβ, PKCε, or TRPV1 inhibited 5-HT-induced me-
chanical hyperalgesia. In ipsilateral DRG neurons, 5-HT in-
jection increased 5-HT or capsaicin-induced calcium signals
mainly in IB4-negative neurons, which was regulated by the 5-
HT2B-PLCβ-PKCε pathway. 5-HT injection caused unilateral
hyperalgesia in injected site and facilitated 5-HT signaling in
ipsilateral DRG. It is likely that plastic changes occur only in
injected peripheral terminal of nociceptors and in ipsilateral
DRG, resulting in peripheral sensitization, inducing ipsilateral
hyperalgesia. Because no facilitated 5-HT responsiveness oc-
curred in contralateral DRG, it is indicated that no signal was
passed to the contralateral side. Thus only unilateral
hyperalgesia was observed after 5-HT injection. A possible
mechanism is that initial insult (5-HT) induces activation of
5-HT2B-PLCβ-PKCε in the peripheral terminal of the noci-
ceptor. Activation of this pathway could relieve TRPV1 from
Fig. 4 Pattern 1 signals are inhibited by 5-HT2B/2C PLCβ and PKCε
inhibitors. a Mice were injected with 5-HT or SB206553 (10 μM)/5-
HT. At 30 min, lumbar 4–6 DRG ipsilateral to the 5-HT-injected
paw and SB206553/5-HT-injected paw were taken and cultured for
12 h. Neurons were then stimulated with 5-HT (1 μM), and
intracellular calcium change was recorded for 600 s. After recording,
the neurons were pulse-labeled with IB4-FITC (5 μg/ml) for 10 min.
Data are mean ± SEM peak values of [Ca2+]i signals (∼35 s after the
addition of 5-HT). Comparison between 5-HT-injected and SB206553-
5-HT-injected neurons was done by two-way ANOVA with a post hoc
Bonferroni test. **p < 0.01. b DRG neurons were pre-incubated with the
PLCβ inhibitor U73122 (5 μM) for 5 min, then stimulated with 5-HT
(1 μM); calcium signals were recorded for 400 s. U73122-treated groups
were compared with untreated groups by two-way ANOVAwith a post
hoc Bonferroni test. *p < 0.05; **p < 0.01. cMicewere injectedwith 5-HT
or PKCεI (50 μM)/5-HT. Lumbar 4–6 DRG were cultured and stimulated
with 5-HT (1 μM); calcium signals were recorded for 200 seconds.
Comparison between 5-HT-injected and PKCεI-5-HT-injected groups
was done by two-way ANOVAwith a post hoc Bonferroni test. *p < 0.05
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PIP2 inhibition (Chuang et al. 2001) to produce peripheral
sensitization that increases the number of neurons responding
to 5-HT and facilitates 5-HTor capsaicin-induced signaling in
IB4-negative neurons (Fig. 8). Thus, 5-HT-induced mechani-
cal hyperalgesia may be mainly mediated by 5-HT2B-Gq-
PLCβ-PKCε signaling by regulating TRPV1 function.
We previously suggested that 5-HT2B mediates 5-HT-
induced mechanical hyperalgesia using 5-HT2B/2C antagonist,
SB206553 (Lin et al. 2011). Interestingly, Urtikova et al.
(2012) found antinociceptive effects of 5-HT2B on neuropath-
ic pain in rats, using 5-HT2B selective antagonist RS127445.
We used RS127445 in our mouse model but found that 0.25
and 0.5 nmol RS1277445 blocked 5-HT-induced mechanical
hyperalgesia. These results confirmed our previous suggestion
that 5-HT2B plays a pro-nociceptive role to mediate 5-HT-
induced mechanical hyperalgesia, although 5-HT2C involve-
ment cannot be completely ignored given that a number of
studies have shown that 5-HT2C receptor has pro-
nociceptive or antinociceptive effects (Jeong et al. 2004;
Nakajima et al. 2009; Nakai et al. 2010). Previous findings
suggested that PLCβ, Gq/11, Gi, PKCε are involved in
carrageenan- or PGE2-inudced mechanical hyperalgesia
(Khasar et al. 1999; Joseph et al. 2007; Dina et al. 2009;
Tappe-Theodor et al. 2012). Blocking PLCβ or PKCε but
not Gi or AC specifically inhibited 5-HT-induced mechanical
hyperalgesia, which further indicates that the Gq-PLCβ-PKCε
pathway is involved in 5-HT-induced mechanical
hyperalgesia. Activation of 5-HT2B induces Gq-PLCβ-
PKCε signaling (Loric et al. 1995; Lin et al. 2011). The de-
pendency of 5-HT-induced mechanical hyperalgesia on the
Fig. 5 5-HT-induced calcium
signals have different sensitivities
to EGTA. Lumbar 4–6 DRG
ipsilateral or contralateral to the 5-
HT-injected mouse paw were
cultured for 12 h, then stimulated
with 5-HT (1 μM), and
intracellular calcium change was
recorded for 600 s. After a
washing, neurons were pre-
incubated with EGTA (2 mM) for
10 min (a–f) or with 5-HT3
antagonist (Granisetron (Gran),
1 μM, g) for 5 min, then
stimulated with 5-HT (1 μM);
calcium signals were recorded for
1400 or 400 s, respectively.
Neurons were then pulse labeled
with IB4-FITC (5 μg/ml) for
10 min. Time-dependent mean
calcium increase in IB4-positive
(a–d) and IB4-negative neurons
(e–f). White bars indicate the
presence of EGTA, black bars
indicate the time for addition of 5-
HT (1 μM). g Granisetron-treated
responses were divided into two
types: unchanged (type 1) and
decreased (type 2). Comparison
between 5-HT treatment alone
and Granisetron/5-HT-treated
groups was done by one-way
ANOVAwith a post hoc
Bonferroni test. *p < 0.05;
**p < 0.01; ***p < 0.001
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Gq-PLCβ-PKCε pathway gives further evidence of the in-
volvement of 5-HT2B. Clearly, 5-HT2B has pro-nociceptive
rather than antinociceptive effects in 5-HT-induced mechani-
cal hyperalgesia. The antinociceptive roles of 5-HT2B on neu-
ropathic pain may be influenced by other inflammatory medi-
ators or immune cells a suggested previously (Urtikova et al.
2012).
Administration of 5-HT into mice increased the number of
DRG neurons responding to 5-HT (Fig. 3) in both IB4-posi-
tive and IB4-negative neurons, suggesting that both types of
neurons are involved in 5-HT-induced pain. However, 5-HT-
evoked transient calcium signals (pattern 1) were enhanced in
only IB4-negative neurons. 5-HT-evoked calcium signals
were greater in IB4-positive than -negative neurons before 5-
HT injection, which may explain the enhanced calcium sig-
nals found only in IB4-negative neurons. IB4-positive and IB4-
negative neurons may play distinct roles in 5-HT-induced
pain. Injection of 5-HT2B/2C antagonist inhibited pattern 1
transient signals in both types of neurons. Given that the 5-
HT2B/2C antagonist blocks only 5-HT-induced mechanical
hyperalgesia (Lin et al.,2011). pattern 1 calcium signals
inhibited by 5-HT2B/2C antagonist may be involved in 5-HT-
induced mechanical hyperalgesia. Accordingly, both IB4-pos-
itive and IB4-negative neurons are involved, although pattern
1 signals in IB4-positive neurons were not enhanced. Stucky
and Lewin (1999) suggested that IB4-negative neurons have
lower action potential (AP) threshold and shorter AP duration
than IB4-positive neurons: IB4-negative neurons could be es-
sential in transducing information about stimuli, but IB4-pos-
itive neurons could be more important for transmission of
information at the first central synapse. 5-HT-induced me-
chanical hyperalgesia is not a chronic effect (lasts 2 h).
Therefore, 5-HT injection greatly enhanced calcium signals
in IB4-negative neurons, which may be responsive for trans-
ducing 5-HT stimuli, rather than in IB4-positive neurons,
which may be important in synaptic transmission. Both types
Fig. 6 5-HT-induced mechanical hyperalgesia is inhibited by peripheral
injection of TRPV1 antagonist or in mice lacking TRPV1. a Wild-type
CD1 mice (8–12 weeks old) were pre-injected with or without 25 μl
TRPV1 antagonist (capsazepine (CZP), 10 μM), then with 25 μl 5-HT
(10 μM). b TRPV1+/+, TRPV1+/−, and TRPV1−/−mice (8–16 weeks old)
were injected with 25μl 5-HT (10 μM). The threshold of pawwithdrawal
(PWT) was measured before (t = 0) and after injection. Data are mean ±
SEM PWTof total tested mice (n = 6 per group). Data for TRPV1+/+ and
TRPV1+/− mice are grouped together. Comparison between 5-HT-
injected and CZP-5HT-injected animals or between ipsilateral side of
TRPV1+/+ and TRPV1−/− animals was done by two-way ANOVA with
a post hoc Bonferroni test. *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 7 Capsaicin-induced calcium influx is enhanced by 5-HT and
inhibited by 5-HT2B/2C antagonist and PKCε blocker. Lumbar 4–6
DRG ipsilateral or contralateral to the 5-HT-injected, SB206553-5-HT,
or PKCεI-5-HT-injected mouse paw were cultured for 12 h, then
stimulated with capsaicin (100 nM), and intracellular calcium change
was recorded for 600 s. After recording, neurons were pulse labeled
with IB4-FITC (5 μg/ml) for 10 min. Peak values of [Ca
2+]i signals
(approximately 35 s after the addition of agonists) represent data points
as indicated. Comparisons between ipsilateral and contralateral sides of 5-
HT-injected animals (number sign), between ispilateral side of 5-HT-
injected and SB206553-5-HT-injected animals (asterisk) or between
ispilateral side of 5-HT-injected and PKCεI-5-HT-injected animals
(asterisk) were done by two-way ANOVA with a post hoc Bonferroni
test. ##p < 0.01; **p < 0.01; ***p < 0.001
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of neurons participate in mechanical hyperalgesia, so the sig-
nals can be inhibited by 5-HT2B/2C antagonist.
In IB4-negative neurons, inhibition of 5-HT2B, PKCε and
PLCβ completely blocked 5-HT-induced pattern 1 calcium
signals, so pattern 1 signals may be regulated by the 5-
HT2B-PLCβ-PKCε pathway. Pattern 1 calcium increase was
also sensitive to the addition of EGTA, which indicates that
the increase was due to calcium influx through calcium chan-
nels. However, the calcium influx was not through 5-HT3
receptor because 5-HT3 receptor antagonist, granisetron, did
not block the calcium influx. 5-HT-induced calcium influx
may occur through other calcium channels in IB4-negative
neurons. In contrast, IB4-positive neurons have more compli-
cated responses. 5-HT-evoked calcium signals were complete-
ly inhibited by 5-HT2B/2C antagonist and PLCβ, but partially
inhibited by PKCεI, suggesting that calcium signals were par-
tially regulated by 5-HT2B-PLCβ-PKCε pathways. Since cal-
cium signals in some IB4-positive neurons were sensitive to
EGTA, it indicated that the part of calcium signals was from
calcium influx. Calcium signals unregulated by PKCε could
directly result from 5-HT2B/2C activation that leads to calcium
release from ER store, which are insensitive to EGTA.
Calcium signals regulated by PKCε could be from voltage-
gated calcium channels or other calcium channels.
Interestingly, 5-HT3 antagonist specifically inhibited calcium
signals of some IB4-positive neurons. Thus, calcium influx
regulated by 5-HT2B-PLCβ-PKCε pathway is more likely
from 5-HT3 channel. 5-HT3 was previously found not in-
volved in 5-HT-induced mechanical hyperalgesia (Lin et al.
2011) but is involved in 5-HT-induced thermal hyperalgesia
(Loyd et al. 2012). Although 5-HT3 antagonist cannot
completely block 5-HT-induced mechanical hyperalgesia, it
shortens the hyperalgesia response (Lin et al. 2011). which
agrees with our finding that pattern 1 signals in some IB4-
positive neurons were mediated by 5-HT3 because such neu-
rons are important in synaptic transmission (Stucky and
Lewin 1999). 5-HT3 could be involved in maintaining me-
chanical hyperalgesia, which is also regulated by 5-HT2B-
PLCβ-PKCε pathway.
Serotonin has been shown to enhance TRPV1 functions
(Sugiuar et al. 2004; Ohta et al. 2006). As expected, we found
that 5-HT injection enhanced capsaicin-evoked calcium sig-
nals but only in IB4-negative not IB4-positive neurons.
Interestingly, capsaicin-evoked calcium signals were greater
in IB4-positive than IB4-negative neurons before 5-HT injec-
tion, which is consistent with the study in rats (Liu et al. 2004)
but not mice (Dirajlal et al. 2003; Breese et al. 2005). The
difference could be due to the outbred mice we used. The
increased capsaicin-evoked calcium signals in IB4-negative
neurons explain the effect of 5-HT injection only in IB4-
Fig. 8 Putative model of 5-HT-induced mechanical hyperalgesia through
5-HT2B-mediated pathways. In the periphery of IB4-negative neurons, 5-
HT2B responds to 5-HT to activate Gq protein and PLCβ, thus activating
PKCε. PKCε activation enhances TRPV1 function, thereby leading to
mechanical hyperalgesia. In the cell body of IB4-negative neurons,
peripheral 5-HT stimulation increases the number of 5-HT-responsive
neurons and 5-HT-evoked calcium signals. Enhanced calcium signals
could be due to regulation of TRPV1 by 5-HT2B-PLCβ-PKCε
pathway. In the periphery of IB4-positive neurons, 5-HT2B responds to
5-HT to activate Gq protein, PLCβ, and PKCε, thereby leading to
mechanical hyperalgesia. In the cell body of IB4-positive neurons,
peripheral 5-HT stimulation increases the number of 5-HT-responsive
neurons
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negative neurons. The capsaicin-evoked signals in IB4-nega-
tive neurons were greatly inhibited by 5-HT2B/2C antagonism
and PKCε blockage, which suggests that 5-HT-enhanced
capsaicin-evoked calcium signals were regulated by the 5-
HT2B/2C-PKCε pathway. Capsaicin-sensitive IB4-negative
neurons have lower mechanical threshold and larger mechan-
ical evoked currents than capsaicin-sensitive IB4-positive neu-
rons (Drew et al. 2002). Therefore, 5-HT-enhanced capsaicin-
evoked calcium signals in IB4-negative neurons may be im-
portant in 5-HT-induced mechanical hyperalgesia.
Administration of a TRPV1 antagonist before 5-HT injection
in mice specifically inhibited 5-HT-induced mechanical
hyperalgesia. Mice lacking the TRPV1 gene did not show
mechanical hyperalgesia in response to 5-HT stimuli, which
suggests that TPRV1 is involved in 5-HT-induced mechanical
hyperalgesia. TRPV1 involvement in mechanical hyperalgesia
is surprising but not impossible. Several lines of evidence have
proposed that TRPV1 antagonists inhibit capsaicin-, acid-, or
CFA-induced mechanical hyperalgesia (Gavva et al. 2005;
Honore et al. 2005; Cui et al. 2006; Chen et al. 2014). Kim
et al. (2012) proposed that spinal TRPV1 plays critical roles in
mediating neuropathic mechanical allodynia. Activation of
spinal TRPV1 could be due to Gq/11-coupled receptors or ar-
achidonic acid (AA) metabolites (Gibson et al. 2008; Kim et
al. 2009; Kim et al. 2012). Given that 5-HT2 receptor activa-
tion can activate phospholipase A2, thus leading to AA release
(Tournois et al. 1998). peripheral 5-HT2B activation by 5-HT
may induce AA release to activate peripheral TRPV1, thus
affecting mechanical hyperalgesia.
Although calcium signals regulated by 5-HT2B are critical
for 5-HT-induced mechanical hyperalgesia, sodium currents
may also have important roles in mechanical hyperalgesia.
Several lines of evidence have suggested that 5-HT increases
tetrodotoxin-resistant (TTX-R) INa currents (Gold et al. 1996).
Nav1.8 (a TTX-R channels) is related to inflammatory
hyperalgesia (Abrahamsen et al. 2008; Yen et al. 2009). and
PKC can modulate TTX-R INa currents (Gold et al. 1998;
Cang et al. 2009). Therefore, 5-HT2B-Gq-PLCβ-PKCε signal-
ing could regulate voltage-gated Na+ channels to affect me-
chanical hyperalgesia.
In conclusion, our study demonstrates that 5-HT2B-Gq-
PLCβ-PKCε signaling and TRPV1 function are involved in
5-HT-induced mechanical hyperalgesia. Peripheral 5-HT stimu-
lation increased the responsiveness of DRG neurons to 5-HT.
The number of both IB4-positive and IB4-negative neurons
responding to 5-HT were increased. 5-HT or capsaicin-evoked
calcium signals were increased in IB4-negative neurons by 5-
HT2B-Gq-PLCβ-PKCε pathway. Accordingly, 5-HT-induced
mechanical hyperalgesia may be mainly mediated by 5-HT2B-
Gq-PLCβ-PKCε signaling by regulating TRPV1 function.
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